Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-07-12 4:34 pm Sale | 13D | ARBUTUS BIOPHARMA CORP ABUS | SVF Investments (UK) Ltd | 0 0% | -16,013,540 (Position Closed) | View |
| 2019-07-12 4:32 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | SVF Investments (UK) Ltd | 0 0% | -22,703,669 (Position Closed) | View |
| 2019-07-12 4:31 pm Sale | 13D | MYOVANT SCIENCES LTD COM MYOV | SVF Investments (UK) Ltd | 0 0% | -40,765,599 (Position Closed) | View |
| 2019-07-12 4:29 pm Sale | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | SVF Investments (UK) Ltd | 0 0% | -105,952,381 (Position Closed) | View |
| 2019-06-05 4:22 pm Purchase | 13D | MYOVANT SCIENCES LTD COM MYOV | SVF Investments (UK) Ltd | 40,765,599 45.56% | 2,424,242 (+6.32%) | View |